VYCO — VYCOR MEDICAL INC

OTC · Health Care · Health Care Equipment & Supplies · CIK 1424768 ·
Last close
$0.06
Market Cap
$1.90M
52W High
$0.07
52W Low
$0.05
ADV30
3,753
Next earnings
Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. The company operates through two segments: Vycor Medical and NovaVision. Its Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation therapies targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals. The company was incorporated in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. operates as a subsidiary of Fountainhead Capital Management Ltd.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 458,540 375,153 45,808 20,108 854,071 173,634 5,083,027
Dec 2025 416,877 335,370 -36,525 -62,686 830,420 86,982 4,917,299
Sep 2025 513,792 451,932 32,085 4,936 941,195 64,230 4,965,388
Jun 2025 496,353 415,271 51,146 23,887 878,946 99,700 4,745,890

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$111,156
Investing CF
$-2,243
Financing CF
$1,968
CapEx
$-1,606
Dividends Paid
Buybacks
EPS Diluted TTM
$-0.01
As of
2026-06-07

Balance + Analyst (yfinance extras)

Retained Earnings
$-33,790,933
Inventory
$181,910
Receivables
$194,041
ST Investments
EBIT TTM
$92,001
Pretax Income TTM
$-11,581
Interest Exp TTM
$103,582
Analysts

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,885,562
EBITDA
$155,215
Free Cash Flow
$441,862
Enterprise Value
$2,709,454
Total Cash
$173,634
Total Debt
$980,812
Shares Out
33,372,796
Trailing EPS
$0.00
Book Value
$-0.12
ROE
ROA
6.4%
Div Yield

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2025 1,863,400 33,900 -72,426 830,420 4,917,299 -13,471
Dec 2024 1,589,324 -9,145 -107,200 998,117 4,688,200 60,110
Dec 2023 1,460,604 40,191 -69,691 992,298 4,317,774 29,430
Dec 2022 1,222,989 -306,514 -404,917 860,178 3,801,049 -217,016

Peers — same industry

TickerNameMarket CapLastDaily %
AEMD AETHLON MEDICAL INC $1.86M $0.71
PREM Premier Air Charter Holdings Inc. $1.97M $0.06
IVF INVO Fertility, Inc. $2.02M $1.13
BJDX Bluejay Diagnostics, Inc. $1.50M $1.45
NUMD Nu-Med Plus, Inc. $1.46M $0.02

News headlines (Yahoo Finance, 1h cache)

Vycor Medical Releases Financial Results for the Three Months Ended March 31, 2026
2026-05-15 19:01 · Yahoo
Vycor Medical Releases Financial Results for the Year Ended December 31, 2025
2026-03-31 18:53 · Yahoo
Vycor Medical Releases Financial Results for the Three and Nine Months Ended September 30, 2025
2025-11-14 15:45 · Yahoo
Vycor Medical Releases Financial Results for the Three and Six Months Ended June 30, 2025
2025-08-08 16:27 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.